- Delivery Method:
- VIA UPS and Electronic Mail
- Issuing Office:
- Center for Tobacco Products
10903 New Hampshire Avenue
Silver Spring, MD 20993
Dear Robin Colbran and Jy Colbran:
The United States Food and Drug Administration’s (FDA) Center for Tobacco Products has completed an evaluation of your corrective actions included in your responses, dated May 26, 2020, June 5, 2020, June 15, 2020, and July 7, 2020, in response to our Warning Letter dated May 22, 2020. Based on our evaluation, it appears that you have taken steps to address the violations contained in the Warning Letter regarding your website https://5150eliquid.com.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to ensure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. This letter also will not preclude any regulatory action should violations be observed in the future.
Division of Promotion, Advertising, and Labeling
Office of Compliance and Enforcement
Center for Tobacco Products
5150 Premium Vape Fluid, Inc.
Attn: Robin Colbran and Jy Colbran
12042 SE Sunnyside Rd, #406
Clackamas, OR 97015
Domains By Proxy, LLC